mCPP: an undesired addition to the ecstasy market
as a discriminative stimulus

by
Bossong M, Brunt T, Van Dijk J, Rigter S, Hoek J, Goldschmidt H, Niesink R.
Drug Information and Monitoring System (DIMS),
Trimbos Institute for Mental Health and Addiction,
Utrecht, The Netherlands.
J Psychopharmacol. 2009 Mar 20.


ABSTRACT

A new ecstasy-like substance, meta-chlorophenylpiperazine (mCPP), has been detected in street drugs in the Netherlands. Theoretically, mCPP possesses the potential to become a non-neurotoxic alternative for methylenedioxymethamphetamine (MDMA), the regular psychoactive substance of ecstasy. Since its introduction on the Dutch market of synthetic drugs, the percentage of mCPP-containing tablets has increased, including both tablets that contain only mCPP and tablets containing a combination of mCPP and MDMA. These tablets occur in many different colours, shapes and sizes and with various logos, making it impossible to distinguish mCPP-containing tablets from regular MDMA tablets. In addition, the reports of users concerning the effects of mCPP are predominantly negative. All these aspects together lead to the conclusion that mCPP is an undesired addition to the ecstasy market from the user's perspective.

MDMA
History
Serotonin
Dopamine
MDMA/MDE
Entactogens
Empathogens
Drugs and reward
Protect and survive
PMMA (from PIHKAL)
Ecstasy and tryptophan
Ecstasy and serotonin synthesis
MDMA, MBDB, fenfluramine, and MMAI


Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family